(Press-News.org) Today, the Innovative Cancer Medicines (ICM) initiative announced the enrollment of the first Nigerian patient in a pioneering demonstration project to provide an immunotherapy drug used to treat cancer. The goal of the initiative is to develop an approach that explores sustainable and effective administration of innovative immuno-oncology therapies in low- and middle-income countries.
The ICM initiative is a collaboration between the Clinton Health Access Initiative (CHAI) and the Parker Institute for Cancer Immunotherapy (PICI), along with Bristol Myers Squibb (BMS) and Roche, working with the National Hospital in Abuja, an oncology center in Nigeria recognized for its excellence.
Low- and middle-income countries, particularly in sub-Saharan Africa, have historically faced challenges in accessing cancer treatments that have been available in high-income countries for decades. Yet Africa is one of the most affected regions globally, with the number of cancer deaths on the continent expected to double by 2040[1]. Among the various cancers affecting the region, colorectal cancer represents a particular concern and is the focus of this initiative. In Nigeria alone, colorectal cancer accounts for approximately 6.4 percent of all cancers and is responsible for nearly 5,900 deaths a year[2]
“This demonstration project will show to the world that we have institutions in Nigeria that are ready, with the right investments, to introduce and sustainably provide innovative diagnostics and medications,” said Dr. Abubakar Bello, Chief Consultant, Clinical and Radiation Oncologist, National Hospital Abuja and the project’s Principal Investigator.
"This milestone shows that Nigerian healthcare institutions can deliver world-class cancer care,” said Dr. Adekunle Iziaq Salako, Hon. Minister of State for Health and Social Welfare, Nigeria. “This demonstration project will provide critical evidence on how advanced immunotherapy can be integrated into our health system."
“This project demonstrates that with the right partnerships and health systems investments, cutting-edge cancer treatments can be delivered with the same operational excellence found anywhere in the world,” said Dr. Olufunke Fasawe, CHAI Vice President of Integration and Country Director, Nigeria.
Over the next two years, the ICM partnership will support the National Hospital Abuja’s demonstration project in Nigeria which features nivolumab, an immunotherapy agent, that is already approved by drug regulators in other countries to address cancers of public health significance. The demonstration project will report on its progress which includes health systems-strengthening investments required to scale up the program.
“Immunotherapy is playing a revolutionary role in the fight against cancer,” said Sean Parker, Founder and Chairman of PICI. “It’s an ethical imperative that access to these lifesaving treatments not be limited to a privileged few. Our goal with ICM is to demonstrate the feasibility of using best-in-class treatments in clinics in low-resource areas and to inspire a bold, multitiered, access-oriented global approach in the fight against cancer. Two decades ago, partners around the world came together to ensure treatment for HIV for millions of people across sub-Saharan Africa. We hope this project inspires a similarly bold, multitiered global approach in the fight against cancer.”
"At Bristol Myers Squibb, we believe everyone should have the opportunity to benefit from medicines and innovations, regardless of geography or circumstance,” said Jasmine Greenamyer, Vice President of Global Purpose and Patient Experience at Bristol Myers Squibb. “Our involvement in the ICM initiative reflects our commitment to co-develop operational excellence and effective administration of innovative immuno-oncology therapies in countries like Nigeria. We are proud to collaborate and accelerate progress for patients and communities.”
“Where you live should not dictate your health, yet we know millions continue to face obstacles to health care,” said Roberto Taboada, Network Lead Anglophone West Africa, Roche Diagnostics, General Manager, Roche Nigeria. “At Roche, we believe that collaboration and cross-sector partnerships are what’s needed to increase access to innovation. The ICM partnership is a great example of the public and private sectors each playing a crucial role to spur and scale innovation. We are excited to see the meaningful difference that this brings to patients in Nigeria, and beyond.”
About the organizations:
The Clinton Health Access Initiative (CHAI) www.clintonhealthaccess.org
The Parker Institute for Cancer Immunotherapy (PICI) www.parkerici.org
Roche www.roche.com
Bristol Myers Squibb (BMS) www.bms.com
[1] The Lancet Oncology Commission
[2] World Health Organization. International Agency for Research on Cancer. https://gco.iarc.fr/today/data/factsheets/populations/566-nigeria-fact-sheets.pdf Accessed 10 September 2025.
END
Global initiative to demonstrate operational excellence in Nigeria for metastatic colorectal cancer patients
2025-10-28
ELSE PRESS RELEASES FROM THIS DATE:
AI produces shallower knowledge than web search
2025-10-28
Learning about a topic by interacting with AI chatbots like ChatGPT rather than following links provided by web search can produce shallower knowledge. Advice given on the basis of this shallow knowledge tends to be sparser, less original, and less likely to be adopted by others. Shiri Melumad and Jin Ho Yun conducted seven experiments with thousands of online participants who were randomly assigned to learn about various topics, including how to plant a vegetable garden, how to lead a healthier lifestyle, or how to cope with financial scams, using either large language models (LLMs) or traditional Google web search links. Participants ...
New study shows global decline in parental trust in childhood vaccines after COVID-19, contributing to increased measles outbreaks
2025-10-28
October 28, 2025 — An international study led by the Azrieli Faculty of Medicine in the Galilee at Bar-Ilan University reveals that the COVID-19 pandemic has contributed to a diminishing public trust in childhood vaccines, resulting in declining vaccination rates and a resurgence of preventable, life-threatening diseases such as measles. The findings come amid one of the most severe measles outbreaks in Israel in decades, with thousands of infections and multiple child deaths reported nationwide.
Published in the peer-reviewed journal Vaccine, the study surveyed 2,047 parents with children born both before and after the pandemic ...
BD² awards $18 million in grants to advance research on the biology of bipolar disorder
2025-10-28
Washington, D.C. – Today, BD², or Breakthrough Discoveries for thriving with Bipolar Disorder, announced its third round of Discovery Research grants, totaling nearly $18 million – expanding a comprehensive global effort to examine the key mechanisms of bipolar disorder. Multidisciplinary teams of scientists and clinicians include leads from the Icahn School of Medicine at Mount Sinai, Mass General Brigham, Weill Cornell Medicine, and the University of Minnesota.
These teams represent a unique cohort of successful Discovery Grantees, as they will all use neuromodulation to explore human neural circuitry in bipolar disorder. These teams will each ...
Opt-out organ donation policies might reduce organ supply
2025-10-28
Every day, 17 Americans die while waiting for an organ transplant. Opt-out organ donation policies, which enroll everyone into post-mortem donation programs by default unless people choose to opt out, have been touted as a way to increase the supply of desperately needed organs. But opt-out organ donation policies may reduce living organ donations, leaving systems no better supplied with lifesaving organs.
Pascal Güntürkün and colleagues analyzed epidemiological data from 24 countries between 2000–2023 and conducted four experimental ...
Message from the oldest-living dogs to dogs and men: Gonad function fights frailty
2025-10-28
West Lafayette, Ind. – Frailty threatens older individuals because it increases their vulnerability to detrimental health outcomes, such as falling, longer hospitalization, or even shortened life expectancy. New research exploring the linkage between frailty and mortality risk points to retaining gonad function as a potent strategy to fight late-life frailty.
The study conducted by scientists at the Gerald P. Murphy Cancer Foundation’s Center for Exceptional Longevity Studies was published last week in the peer-reviewed scientific journal Scientific Reports.
The ...
Distinct brain features in football players may tell who is at risk of long-term traumatic disease
2025-10-28
Brain scans from American football players reveal subtle differences in the brain’s outer grooves when compared to scans from otherwise healthy men who never played contact or collision sports, a new study shows. Its authors say the findings could potentially predict which people are more at risk of chronic traumatic encephalopathy (CTE).
Like many neurodegenerative diseases, CTE is known to worsen over time, and it afflicts many who play contact and collision sports that involve repeated hits to the head. Popular contact sports include soccer and basketball, while common collision sports are ...
Identifying safer implant designs for total hip replacement
2025-10-28
As populations continue to age, total hip replacement (THR) is becoming an increasingly common surgical procedure. Experts estimate that approximately one million THRs are performed each year worldwide. The surgery is often life-changing, as it can fully restore the function of the hip joint, reduce pain, and allow patients to walk and bear weight again. However, as with any major surgery, the procedure is not without risks, especially for older individuals with other health conditions.
A significant complication following THR is a femoral fracture—a break in the thigh bone near the artificial hip joint. This ...
Study reveals clinical frailty scale as a quick predictor of patient risk after heart failure administration
2025-10-28
Frailty is closely linked to adverse outcomes in older adults, particularly those with heart failure. Numerous epidemiologic studies show that frailty has important prognostic value in this population, underscoring the need for routine assessment. At the same time, the concept of frailty has expanded beyond the physical domain to include cognitive and other dimensions, making comprehensive evaluation increasingly complex and less feasible in everyday practice. The Clinical Frailty Scale (CFS) offers a practical alternative: a 9-point, bedside, visually assessed tool that can be completed in minutes. However, key questions remain—how closely ...
Game-changing heat shield to revolutionize aerospace manufacturing with long-life engines
2025-10-28
Aerospace industry has undergone tremendous developments over the last century, with materials science engineers playing a significant role in this transformation. It is well known that as the operating temperature of metallic materials increases, the speed of aircraft can be enhanced and fuel consumption can be reduced. Therefore, research on high-temperature materials has been directly linked to the improvement of aircraft performance and has been actively conducted worldwide since the 1940s.
For more than 80 years, Ni-based alloys have been the primary materials used for high-temperature applications. To enable their use at even higher temperatures, ...
Pusan National University researchers show how AI can help in fashion trend prediction
2025-10-28
Fashion trend forecasting helps companies predict which clothes will be popular in upcoming seasons. Traditionally, this has relied on experts’ intuition, experience and creativity. More recently, big-data analysis has been incorporated, offering deeper insights into consumer behavior. However, such methods pose technical barriers and remain out of reach for fashion students or small brands.
Recent developments in artificial intelligence (AI) can balance the scales. Large language models (LLMs) like ChatGPT have made big data analysis readily available to the public. LLMs draw ...